dc.creatorTaniguti, Ana Paula Tiemi
dc.creatorPertille, Adriana
dc.creatorMatsumura, Cíntia Yuri
dc.creatorSanto Neto, Humberto
dc.creatorMarques, Maria Julia
dc.date2011-Jan
dc.date2015-11-27T13:22:10Z
dc.date2015-11-27T13:22:10Z
dc.date.accessioned2018-03-29T01:14:23Z
dc.date.available2018-03-29T01:14:23Z
dc.identifierMuscle & Nerve. v. 43, n. 1, p. 82-7, 2011-Jan.
dc.identifier1097-4598
dc.identifier10.1002/mus.21869
dc.identifierhttp://www.ncbi.nlm.nih.gov/pubmed/21108244
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/199751
dc.identifier21108244
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1299984
dc.descriptionFibrosis is a pathological feature observed in patients with Duchenne muscular dystrophy (DMD) and in mdx mice, the experimental model of DMD. We evaluated the effect of suramin, a transforming growth factor-beta 1 (TGF-β1) blocker, on fibrosis in mdx mice. mdx mice (6 months old) received suramin for 7 weeks. Suramin- and saline-treated (control) mdx mice performed exercise on a treadmill to worsen disease progression. Immunoblotting showed an increase of TGF-β1 in mdx diaphragm, limb, and cardiac muscles. Suramin decreased creatine kinase in mdx mice and attenuated fibrosis in all muscles studied, except for cardiac muscle. Suramin protected limb muscles against damage and reduced the exercise-induced loss of strength over time. These findings support a role for TGF-β1 in fibrinogenesis and myonecrosis during the later stages of disease in mdx mice. Suramin might be a useful therapeutic alternative for the treatment of dystrophinopathies.
dc.description43
dc.description82-7
dc.languageeng
dc.relationMuscle & Nerve
dc.relationMuscle Nerve
dc.rightsfechado
dc.rights
dc.sourcePubMed
dc.subjectAnimals
dc.subjectCreatine Kinase
dc.subjectDisease Models, Animal
dc.subjectFemale
dc.subjectFibrosis
dc.subjectMale
dc.subjectMice
dc.subjectMice, Inbred C57bl
dc.subjectMice, Inbred Mdx
dc.subjectMuscle Fibers, Skeletal
dc.subjectMuscle, Skeletal
dc.subjectNecrosis
dc.subjectPhysical Conditioning, Animal
dc.subjectSuramin
dc.subjectTransforming Growth Factor Beta1
dc.titlePrevention Of Muscle Fibrosis And Myonecrosis In Mdx Mice By Suramin, A Tgf-β1 Blocker.
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución